Hill Emily Luisa Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
20
Insider Sells Sum
$1.82M

Insider Activity of Hill Emily Luisa

According to the SEC Form 4 filings, Hill Emily Luisa, being in a position of

  1. Chief Financial Officer at Replimune Group, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 28516 shares for $320,341,
    over all time since 2024-08-16, has bought 0 shares, and sold 49143 shares for $480,894.

Biography of Hill Emily Luisa

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $320,3413100

Comparison of Insiders on Amount of Buys and Sells

2026-08-17SaleReplimune Group, Inc.
REPL
Chief Financial Officer
9,256
0.0093%
$14.28$132,176-9.77%
2026-08-10SaleReplimune Group, Inc.
REPL
Chief Financial Officer
11,448
0.0117%
$12.97$148,481-3.11%
2026-05-18SaleReplimune Group, Inc.
REPL
Chief Financial Officer
7,812
0.0096%
$5.08$39,685+136.93%
2025-08-15SaleReplimune Group, Inc.
REPL
Chief Financial Officer
9,154
0.0113%
$5.37$49,157+42.09%
2025-05-20SaleReplimune Group, Inc.
REPL
Chief Financial Officer
2,535
0.0029%
$8.05$20,407-17.19%
2024-08-16SaleReplimune Group, Inc.
REPL
Chief Financial Officer
8,938
0.0137%
$10.18$90,989+8.41%
2023-03-27SalePTC Therapeutics, Inc.
PTCT
CHIEF FINANCIAL OFFICER
7,363
0.0098%
$45.00$331,335-32.85%
2023-01-31SalePTC Therapeutics, Inc.
PTCT
CHIEF FINANCIAL OFFICER
575
0.0008%
$45.63$26,236-12.4%
2023-01-24SalePTC Therapeutics, Inc.
PTCT
CHIEF FINANCIAL OFFICER
223
0.0003%
$47.45$10,582-14.68%
2023-01-11SalePTC Therapeutics, Inc.
PTCT
CHIEF FINANCIAL OFFICER
418
0.0006%
$44.36$18,542-10.8%
2023-01-10SalePTC Therapeutics, Inc.
PTCT
CHIEF FINANCIAL OFFICER
497
0.0007%
$42.93$21,338-7.73%
2023-01-09SalePTC Therapeutics, Inc.
PTCT
CHIEF FINANCIAL OFFICER
758
0.001%
$41.66$31,575-1.51%
2022-03-31SalePTC Therapeutics, Inc.
PTCT
CHIEF FINANCIAL OFFICER
7,910
0.0112%
$37.78$298,824+18.09%
2022-02-01SalePTC Therapeutics, Inc.
PTCT
Chief Financial Officer
553
0.0008%
$40.00$22,121+0.52%
2022-01-25SalePTC Therapeutics, Inc.
PTCT
Chief Financial Officer
211
0.0003%
$39.31$8,295+3.19%
2022-01-07SalePTC Therapeutics, Inc.
PTCT
Chief Financial Officer
800
0.0011%
$38.52$30,820+5.33%
2022-01-04SalePTC Therapeutics, Inc.
PTCT
Chief Financial Officer
173
0.0002%
$41.16$7,121-1.93%
2021-02-01SalePTC Therapeutics, Inc.
PTCT
Chief Financial Officer
541
0.0008%
$56.96$30,813-28.16%
2021-01-25SalePTC Therapeutics, Inc.
PTCT
Chief Financial Officer
275
0.0004%
$62.05$17,065-35.37%
2021-01-08SalePTC Therapeutics, Inc.
PTCT
Chief Financial Officer
9,278
0.0136%
$69.75$647,141-38.46%
Total: 25
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.